Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Marcos MUCENIC"'
Autor:
Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Matheus V. Fernandes, Marcos Mucenic
Publikováno v:
Annals of Hepatology, Vol 29, Iss 2, Pp 101184- (2024)
Introduction and Objectives: Liver transplantation is the optimal treatment for patients with early hepatocellular carcinoma and cirrhosis. However, hepatocellular carcinoma recurs in approximately 15 % of individuals. This study aimed to assess the
Externí odkaz:
https://doaj.org/article/7fc343926fbf4e3fb9d0da5bc57eca7e
Autor:
Santiago Rodrıguez, Alfeu de Medeiros Fleck, Jr., Marcos Mucenic, Claudio Marroni, Ajacio Brandão
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100500- (2021)
Background: In Brazil, the Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for deceased donor liver transplantation (DDLT). Patients with hepatocellular carcinoma (HCC) receive standardized MELD exception points to accou
Externí odkaz:
https://doaj.org/article/3eaf56dde12b4dc6a7f9522f79df98d4
Autor:
Marcos Mucenic, Ajacio Bandeira de Melo Brandão, Claudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Maria Lucia Zanotelli, Ian Leipnitz, Mário Henrique Meine, Guillermo Kiss, Juliano Martini, Eduardo Soares Schlindwein, Ane Micheli Costabeber, Fernanda Karlinsky Rodrigues Sacco, Giovana Rossato, Guido Pio Cracco Cantisani
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 61, Iss 0 (2019)
ABSTRACT Chronic Hepatitis C relapse after liver transplantation can lead to graft failure within a short time period. The high efficacy and good safety profile of direct-acting antivirals has led to consensual recommendations for using interferon-fr
Externí odkaz:
https://doaj.org/article/1a86acac792b4e9d922af31469fed7f6
Publikováno v:
Arquivos de Gastroenterologia, Vol 42, Iss 4, Pp 249-255 (2005)
BACKGROUND: Due to the risks related to long-term treatment with prednisone and azathioprine, most clinicians try to withdraw these drugs when patients with autoimmune hepatitis are in remission. However, there is a high probability of relapse, and m
Externí odkaz:
https://doaj.org/article/63feaf1498af4d9eb17107f84f562510
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 44, Iss 5, Pp 261-264 (2002)
Portal vein aneurysm is a rare medical entity that can be caused by chronic hepatic diseases with portal hypertension. We describe a 45-year-old man with variceal bleeding from hepatosplenic schistosomiasis and an incidentally found intrahepatic aneu
Externí odkaz:
https://doaj.org/article/31f1454b868f4a5393aefbbc17901b22
Autor:
Santiago RODRÍGUEZ, Alfeu de Medeiros FLECK JR, Marcos MUCENIC, Cláudio MARRONI, Ajacio BRANDÃO
Publikováno v:
Arquivos de Gastroenterologia
ABSTRACT BACKGROUND: In Brazil, the Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for deceased donor liver transplantation (DDLT). Patients with hepatocellular carcinoma (HCC) receive standardized MELD exception points
Externí odkaz:
https://doaj.org/article/27a31d01ce4144a4b57343e5357c5f95
Publikováno v:
Artificial Intelligence in Gastroenterology. 3:21-27
Autor:
Guilherme Gonçalves Pretto, Leandro Totti Cavazzola, Mariana Kumaira Fonseca, Júlia Iaroseski, João Vicente Machado Grossi, Marcos Mucenic
Publikováno v:
Videoscopy. 31
Autor:
Ajácio Bandeira de Mello Brandão, Santiago Rodríguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck, Marcos Mucenic
Publikováno v:
Arquivos de Gastroenterologia, Volume: 57, Issue: 1, Pages: 19-23, Published: 10 FEB 2020
Arquivos de Gastroenterologia v.57 n.1 2020
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia
Arquivos de Gastroenterologia v.57 n.1 2020
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia
BACKGROUND: In Brazil, the Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for deceased donor liver transplantation (DDLT). Patients with hepatocellular carcinoma (HCC) receive standardized MELD exception points to accou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fdea913af9253111a268fde151cd345
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032020000100019&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032020000100019&lng=en&tlng=en
Autor:
F.K.F. Sacco, A. Medeiros Fleck, Maria Lucia Zanotelli, E. Soares Schlindwein, Cláudio Augusto Marroni, J. Martini, Mario Henrique Mendes de Mattos Meine, Ane Micheli Costabeber, Marcos Mucenic, A. Bandeira de Mello Brandao, G.P. Cracco Cantisani, Guillermo Kiss, Ian Leipnitz
Publikováno v:
Transplantation proceedings. 50(3)
Treatment with direct-acting antiviral drugs in interferon-free regimens is currently recommended for viral hepatitis C recurrence after liver transplantation. There are limited data regarding its results in this population, and no optimal treatment